Roche provides an update on the phase III COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 associated pneumonia

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice